Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 17:369:m1780.
doi: 10.1136/bmj.m1780.

Spending and quality after three years of Medicare's bundled payments for medical conditions: quasi-experimental difference-in-differences study

Affiliations

Spending and quality after three years of Medicare's bundled payments for medical conditions: quasi-experimental difference-in-differences study

Joshua A Rolnick et al. BMJ. .

Abstract

Objective: To evaluate whether longer term participation in the bundled payments for care initiative (BPCI) for medical conditions in the United States, which held hospitals financially accountable for all spending during an episode of care from hospital admission to 90 days after discharge, was associated with changes in spending, mortality, or health service use.

Design: Quasi-experimental difference-in-differences analysis.

Setting: US hospitals participating in bundled payments for acute myocardial infarction, congestive heart failure, chronic obstructive pulmonary disease (COPD), or pneumonia, and propensity score matched to non-participating hospitals.

Participants: 238 hospitals participating in the Bundled Payments for Care Improvement initiative (BPCI) and 1415 non-BPCI hospitals. 226 BPCI hospitals were matched to 700 non-BPCI hospitals.

Main outcome measures: Primary outcomes were total spending on episodes and death 90 days after discharge. Secondary outcomes included spending and use by type of post-acute care. BPCI and non-BPCI hospitals were compared by patient, hospital, and hospital market characteristics. Market characteristics included population size, competitiveness, and post-acute bed supply.

Results: In the 226 BPCI hospitals, episodes of care totaled 261 163 in the baseline period and 93 562 in the treatment period compared with 211 208 and 78 643 in the 700 matched non-BPCI hospitals, respectively, with small differences in hospital and market characteristics after matching. Differing trends were seen for some patient characteristics (eg, mean age change -0.3 years at BPCI hospitals v non- BPCI hospitals, P<0.001). In the adjusted analysis, participation in BPCI was associated with a decrease in total episode spending (-1.2%, 95% confidence interval -2.3% to -0.2%). Spending on care at skilled nursing facilities decreased (-6.3%, -10.0% to -2.5%) owing to a reduced number of facility days (-6.2%, -9.8% to -2.6%), and home health spending increased (4.4%, 1.4% to 7.5%). Mortality at 90 days did not change (-0.1 percentage points, 95% confidence interval -0.5 to 0.2 percentage points).

Conclusions: In this longer term evaluation of a large national programme on medical bundled payments in the US, participation in bundles for four common medical conditions was associated with savings at three years. The savings were generated by practice changes that decreased use of high intensity care after hospital discharge without affecting quality, which also suggests that bundles for medical conditions could require multiple years before changes in savings and practice emerge.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the Commonwealth Fund for the submitted work; JAR reported consulting fees from Tuple Health. ASN reported receiving grants from Hawaii Medical Service Association, Anthem Public Policy Institute, the Healthcare Research and Education Trust, Cigna, Ochsner Health System, United Healthcare Blue Cross Blue Shield of NC, and Oscar Health; personal fees from Navvis Healthcare, Navigant, National University Health System – Singapore, Singapore Ministry of Health, the Medicare Payment Advisory Commission, and Agathos; personal fees and equity from NavaHealth; equity from Embedded Healthcare; speaking fees from the Cleveland Clinic; serving as a board member of Integrated Services. without compensation, and an honorarium from Elsevier Press, none of which are related to this manuscript. Since 2016, EJE reports speaker’s fees from Tanner Healthcare System, Mid-Atlantic Permanente Group, American College of Radiology, Marcus Evans, Loyola University, Oncology Society of New Jersey, Good Shepherd Community Care, Remedy Partners, Medzel, Kaiser Permanente Virtual Medicine, Wallace H Coulter Foundation, Lake Nona Institute, Allocation, Partners Chicago, Pepperdine University, Huron, American Case Management Association, Philadelphia Chamber of Commerce, Blue Cross Blue Shield Minnesota, UnitedHealth Group, Futures Without Violence, CHOP, Washington State Hospital Association, Association of Academic Health Centers, Blue Cross Blue Shield of Massachusetts, American Academy of Ophthalmology, Lumeris, Roivant Sciences, Medical Specialties Distributors, Vizient University Healthcare System, Center for Neuro-Degenerative Research, Colorado State University, Genentech Oncology, Council of Insurance Agents and Brokers, Grifols Foundation, America’s Health Insurance Plans, Montefiore Physician Leadership Academy, Greenwall Foundation, Medical Home Network, HFMA, Ecumenical Center – UT Health, American Association of Optometry, Associação Nacional de Hospitais Privados, National Alliance of Healthcare Purchaser Coalitions, Optum Laboratories, Massachusetts Association of Health Plans, District of Columbia Hospital Association, Washington University. Since January 2017, EJE has been a venture partner with Oak HC/FT, a firm that invests in health services but not pharmaceuticals or devices. EJE is on the board of two start-ups: Village MD and Oncology Analytics. EJE has investments in Gilead, Allergan, Amgen, Baxter, and UnitedHealth Group.

Figures

Fig 1
Fig 1
Risk adjusted changes in spending associated with hospital participation in bundled payments for care improvement for four medical conditions, 2011-16. The associations between participation in the bundled payments for care improvement initiative (BPCI) and changes in spending were estimated with separate difference-in-differences models, using a hospital condition specific indicator of entry to the BPCI programme, patient and time varying market characteristics, and quarterly time and hospital fixed effects. All models were generalized linear models with a log-link function and gamma distribution. Low volume hospitals with fewer than 10 episodes for each condition were treated as a single hospital to enable clustered models to converge for the skilled nursing facility care and outpatient professional fees outcomes. BPCI hospital participation was associated with a decrease in all institutional post-acute care spending and skilled nursing facility care spending specifically, as well as outpatient professional fees, combined with increases in spending for home health services
Fig 2
Fig 2
Risk adjusted changes in mortality and use associated with hospital participation in bundled payments for care improvement for four medical conditions, 2011-16. The associations between participation in the bundled payments for care improvement initiative (BPCI) and changes in mortality and use were estimated with separate difference-in-differences models, using a hospital condition specific indicator of entry to the BPCI programme, patient and time varying market characteristics, and quarterly time and hospital fixed effects. All models were ordinary least squares except for total number of days for skilled nursing facility care we used a generalized linear model with log-link function and negative binomial distribution. BPCI hospital participation was not associated with a change in the primary outcome of 90 day mortality. BPCI hospital participation was associated with a differential decrease in total days for skilled nursing facility care. *Reported estimate is a percent (not percentage point) difference

References

    1. White RS, Sastow DL, Gaber-Baylis LK, Tangel V, Fisher AD, Turnbull ZA. Readmission rates and diagnoses following total hip replacement in relation to insurance payer status, race and ethnicity, and income status. J Racial Ethn Health Disparities 2018;5:1202-14. 10.1007/s40615-018-0467-0 - DOI - PubMed
    1. Ellis RP, Chen T, Luscombe CE. Comparisons of health insurance systems in developed countries. Boston University Department of Economics working paper series. 2014;1.
    1. Struijs JN, Baan CA. Integrating care through bundled payments--lessons from The Netherlands. N Engl J Med 2011;364:990-1. 10.1056/NEJMp1011849 - DOI - PubMed
    1. de Bakker DH, Struijs JN, Baan CB, et al. Early results from adoption of bundled payment for diabetes care in the Netherlands show improvement in care coordination. Health Aff (Millwood) 2012;31:426-33. 10.1377/hlthaff.2011.0912 - DOI - PubMed
    1. Pross C, Geissler A, Busse R. Measuring, reporting, and rewarding quality of care in 5 nations: 5 policy levers to enhance hospital quality accountability. Milbank Q 2017;95:136-83. 10.1111/1468-0009.12248 - DOI - PMC - PubMed

Publication types